Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - verapamil - verapamil

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

towa pharmaceutical s.p.a. - verapamil - verapamil

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

laboratori guidotti s.p.a. - zofenopril - zofenopril

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - finasteride - finasteride

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - amisulpride - amisulpride

Unione Europea - italiano - EMA (European Medicines Agency)

actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. l'effetto di imatinib sull'esito del trapianto di midollo osseo non è stata determinata. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. l'esperienza con imatinib in pazienti con mds/mpd associate a riarrangiamenti del gene pdgfr è molto limitata. non ci sono studi clinici controllati che dimostrano un beneficio clinico o un aumento della sopravvivenza per queste malattie.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - zofenopril - zofenopril

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

atnahs pharma switzerland ag - propranololi hydrochloridum - compresse rivestite con film - propranololi hydrochloridum 10 mg, lactosum monohydricum 79 mg, carmellosum calcicum, gelatina, magnesii stearas, Überzug: hypromellosum, glycerolum, e 171, e 120, pro compresso obducto. - beta-dei recettori adrenergici - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

atnahs pharma switzerland ag - propranololi hydrochloridum - compresse rivestite con film - propranololi hydrochloridum 40 mg, lactosum monohydricum 147.4 mg, carmellosum calcicum, gelatina, magnesii stearas, Überzug: hypromellosum, glycerolum, e 171, e 120, pro compresso obducto. - beta-dei recettori adrenergici - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - propranololi hydrochloridum - compresse rivestite con film - propranololi hydrochloridum 10 mg, lactosum monohydricum 50 mg, maydis amylum, solani amylum, cellulosum microcristallinum, carboxymethylamylum natricum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, talcum, polysorbatum 80, macrogolum 6000, pro compresso obducto corresp. natrium 0.13 mg. - beta-dei recettori adrenergici - synthetika